GET DAILY SIGNALSHuntsman (HUN) Eyes +12.5% Move Toward $11 Analyst Target
Key Takeaways
- The central target of $11 is the average of the verified analyst price targets that sit above Huntsman's current share price, not the headline consensus of all targets.
- Huntsman Corporation (HUN) traded near $9.78 at the November 11, 2026 close, meaning the stock would need to rise roughly 12.5% to reach $11.
- Across about a dozen recent analyst targets, the full range runs from $9 to $13, with an overall mean near $10.2; the higher above-price average reflects a wide spread of cautious and constructive views.
- The strongest support comes from the planned merger with Olin Corporation (OLN), expected to close in the first quarter of 2027, plus cost reductions and pricing discipline that management says are driving more than $100 million of year-over-year EBITDA improvement.
- The biggest risks are weak polyurethane (MDI) demand, soft housing and China end-markets, elevated European energy costs, and a stretched, unprofitable recent earnings profile.
- You can find more on Huntsman's Major News, Today's Price Move, Forecast, and Earnings on dedicated Tickeron pages.
Analyst Price Targets and Consensus View
Huntsman carries meaningful analyst coverage, yet the sell-side views remain unusually spread out. Reviewing roughly a dozen recent, individually attributable targets from firms including KeyBanc, Jefferies, Bank of America, Wells Fargo, RBC Capital, Barclays, Goldman Sachs, UBS, Citigroup, Mizuho, Deutsche Bank, and J.P. Morgan, the current range spans $9 to $13. The overall mean of these targets sits close to $10.2, only modestly above the prevailing share price.
Because that overall average lies less than 10% above the current price, the central target here is calculated from the subset of targets above the current price. That above-price average is $11, and it is this figure used throughout the analysis. The most constructive views come from KeyBanc (Overweight, $13) and Jefferies (Buy, $12, set by analyst Daniel Rizzo), while the most cautious come from Bank of America, Wells Fargo, RBC, UBS, and Citi, each clustered at $9.
The reasoning splits along familiar lines: bulls point to merger synergies and cost savings, while bears and neutrals cite persistently weak MDI markets, soft housing demand, and margin pressure. The ratings distribution leans heavily toward Hold and Sell, reflecting limited conviction in either direction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
At a recent price near $9.78, reaching $11 would require a gain of roughly 12.5% — a move that is meaningful but modest relative to the stock's own history. Huntsman's 52-week range spans roughly $8.00 to $16.09, so an $11 print would still leave the shares well below their prior highs.
The path is complicated by fundamentals. Third-quarter 2026 results showed sales of about $1.72 billion that beat expectations, but adjusted EPS of roughly $0.04 missed consensus, and fourth-quarter EBITDA guidance of $60 million to $80 million came in below the roughly $72 million consensus. Management reiterated its target of more than $100 million of full-year EBITDA improvement, and the Olin merger — expected to close in Q1 2027 — adds strategic upside but also execution uncertainty.
What Could Support a Move Toward the Target
- Merger synergy potential: The Olin combination is expected to create a roughly $14 billion specialty-chemicals company, and KeyBanc initiated coverage with an Overweight rating partly on those synergies.
- Cost and pricing discipline: Management has emphasized cost reductions, price increases, and product-mix improvements as EBITDA supports.
- Valuation and income: The stock trades at a low price-to-book multiple and carries a dividend yield near 3.7%, supported by two decades of consecutive payouts.
- Recent analyst firming: KeyBanc and Jefferies raised or maintained above-price targets in November 2026, a modest sign of stabilizing sentiment.
What Could Prevent the Target From Being Reached
- Weak MDI and polyurethane markets: Overcapacity and soft pricing in the core polyurethanes segment remain a persistent drag.
- Macro headwinds: Soft housing, muted Chinese domestic demand, and high European energy costs weigh on volumes and margins.
- Negative earnings: Trailing EPS is negative, and the company posted a net loss in the third quarter, keeping valuation multiples unattractive on a P/E basis.
- Merger execution risk: Integration costs, regulatory hurdles, or a delayed close could undermine the synergy case that underpins the higher targets.
Technical Levels and Market Structure
Huntsman has traded in a wide, volatile range. The 52-week low near $8.00 acts as a key support level, while the $9 area — where several analysts' targets cluster — has served as a recent consolidation zone. On the upside, $11 and then $12–$13 represent natural resistance levels that correspond to the above-price analyst targets. A sustained move through $11 would open the door toward the prior $13–$16 region, though the stock would need to break decisively above its recent trading band to establish a durable uptrend. From what I see, monitoring volume at these levels remains important.
Time Horizon and What Investors Should Monitor
Most analyst price targets reflect a research horizon of roughly 12 months, though the pending Olin merger compresses the relevant catalyst timeline into early 2027. Investors should watch the merger's closing timeline and terms, quarterly earnings and EBITDA guidance, MDI pricing and demand trends, any further analyst target revisions, and broader signals from housing and China demand. Dividend sustainability and balance-sheet metrics also matter given the current loss-making position. None of these items provides a guaranteed outcome for the $11 target. I’m watching this closely as the merger timeline firms up.
AI Daily Buy/Sell Signals
In my research process, Tickeron’s AI Daily Buy/Sell Signals provide a practical way to monitor thousands of stocks and ETFs with AI-driven Buy, Sell, or Hold signals that adapt to changing market conditions and technical behavior. For a volatile, catalyst-heavy name like Huntsman, these signals can serve as a useful complement to fundamental work by highlighting potential shifts in trend or momentum without replacing deeper analysis.
Final Assessment
The central $11 target for Huntsman represents the average of analyst price targets above the current price, not a consensus forecast, and implies a roughly 12.5% move from recent levels near $9.78. The supporting case rests on Olin merger synergies, cost reductions, and a stabilizing analyst tone, while the obstacle list is substantial: weak MDI demand, negative earnings, macro softness, and execution risk around the pending combination. With most analysts clustered at Hold or Sell near $9 and only a handful constructive above $11, the range of views is genuinely wide. The $11 level is a credible but not assured objective, and the merger outcome, EBITDA trajectory, and end-market demand will be the decisive variables to monitor.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
HUN's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Oscillator for HUN moved out of overbought territory on November 03, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 instances where the indicator moved out of the overbought zone. In 17 of the 19 cases the stock moved lower in the days that followed. This puts the odds of a move down at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 56 cases where HUN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HUN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
HUN broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on HUN as a result. In 59 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for HUN just turned positive on October 15, 2026. Looking at past instances where HUN's MACD turned positive, the stock continued to rise in 33 of 49 cases over the following month. The odds of a continued upward trend are 67%.
HUN moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HUN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +10.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where HUN advanced for three days, in 163 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 106 of 147 cases where HUN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.616) is normal, around the industry mean (1.147). P/E Ratio (-9.000) is within average values for comparable stocks, (3.243). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (3.769). Dividend Yield (0.037) settles around the average of (0.195) among similar stocks. P/S Ratio (0.269) is also within normal values, averaging (0.578).
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. HUN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of chemicals for the plastics, automotive and construction industries
Industry ChemicalsMajorDiversified
Advertisement